Wilson Thomas Barham, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2802 Kilpatrick Blvd, Monroe, LA 71201 Phone: 318-855-6282 Fax: 318-855-6424 |
David Rene Dugas, MD Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2802 Kilpatrick Blvd, Monroe, LA 71201 Phone: 318-322-3066 Fax: 318-387-5623 |
Dr. Lee Anthony Miller, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2802 Kilpatrick Blvd, Monroe, LA 71201 Phone: 318-855-6282 Fax: 318-855-6424 |
Dr. Joel W Norris, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2516 Broadmoor Blvd, Monroe, LA 71201 Phone: 318-812-1125 Fax: 318-812-1129 |
Dr. Henry Govan Taliaferro, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2516 Broadmoor Blvd, Monroe, LA 71201 Phone: 318-812-1125 Fax: 318-812-1129 |
News Archive
The diabetes population in the United States will almost double over the next 25 years and annual medical spending on the disease is projected to hit $336 billion, up from $113 billion today, according to a study published in the December issue of Diabetes Care. The National Changing Diabetes® Program (NCDP), a program of Novo Nordisk, commissioned the analysis by a team from the University of Chicago.
A new meta-analysis examining the effect of antioxidant supplements on all-cause mortality published in the Feb. 28, 2007 issue of the Journal of the American Medical Association (JAMA) misuses meta-analysis methods to create generalized conclusions that may inappropriately confuse and alarm consumers who can benefit from supplementing with antioxidants, said the Council for Responsible Nutrition (CRN).
The Boston Globe: "President Barack Obama said Tuesday he'll bring in high-tech bounty hunters to help root out health care fraud, grabbing a populist idea with bipartisan backing in his final push to overhaul the system. ... Obama's anti-fraud announcement was aimed directly at the political middle."
Toshiba America Medical Systems, Inc. has introduced the CAT-880B, a new hybrid catheterization table, for its five-axis InfinixTM-i cardiovascular X-ray line.
POZEN Inc. (NASDAQ:POZN), today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for VIMOVO™ (enteric-coated naproxen / immediate release esomeprazole magnesium, formerly know as PN 400).
› Verified 7 days ago